NCT06853951RecruitingPhase 3
Cardioprotection on Chemotherapy-Induced Cardiotoxicity
The Effect of Cardioprotective Medications on Chemotherapy-Induced Cardiotoxicity in Childhood Acute Leukemia
Source: ClinicalTrials.gov · Last updated 3 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of the present study is to evaluate the protective impact of cardioprotective medications on the chemotherapy- induced cardiotoxicity.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 21 Feb 2025
- Start date
- 18 Jul 2023
- Primary completion date
- 30 Mar 2025
- Lead sponsor
- Ain Shams University
- Diseases
- Childhood cancers
- NCT number
- NCT06853951
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 30
- From 18 Jul 2023 to the primary completion date, 30 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Documented allergy to cardioprotective medications
Who the study is looking for
- Willingness of the legal representative of research participant to participate in the study by giving "informed consent."
- Ability to take oral medication.
- Age 2-18 years at the time of diagnosis.
Age in the registry: 1 year to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of Pharmacy, Ain Shams University Coordinator of this site? Confirm its status | Cairo | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.